Renewal Fuels, Inc. (OTC: RNWF), doing business as American Fusion, announced the appointment of Fabrice David as an independent director, effective Feb. 23, 2026. David brings over two decades of experience in fusion-related energy science, advanced nuclear phenomena, and applied biotechnology. He has authored or co-authored more than 130 scientific publications and holds numerous patents in advanced energy systems and experimental physics.
David previously served as partner and board member of DEUO Dynamics in the United Kingdom, where he provided governance and oversight of advanced fusion and cold-fusion research initiatives. He also founded and operated a photovoltaic solar distribution business, adding commercial experience to his scientific background. As independent director, David will provide scientific and technical oversight and advise on intellectual property strategy as the company advances its Texatron aneutronic fusion platform toward commercial deployment.
The appointment signals American Fusion's commitment to strengthening its scientific foundation. According to the company, David's expertise will be instrumental in guiding the development of its proprietary fusion technology. The full press release is available at https://ibn.fm/WNuzg.
Renewal Fuels, Inc. is an advanced energy platform company focused on fusion energy technologies through its wholly owned subsidiary, Kepler Fusion Technologies. Following a previously announced merger with Kepler, the company is operating under the American Fusion brand and has filed a corporate action with FINRA to change its legal name to American Fusion Inc. The company's strategy centers on building a scalable, infrastructure-grade fusion energy platform supported by proprietary technology and disciplined intellectual property development.
The appointment comes at a critical time for the fusion energy sector, which is attracting increased investment and regulatory attention as a potential clean energy source. Aneutronic fusion, the focus of American Fusion's Texatron platform, promises reduced radioactive byproducts compared to traditional fusion approaches, potentially accelerating commercialization. David's background in both scientific research and business operations positions him to bridge technical development with strategic planning.
For investors tracking the company, the latest news and updates relating to RNWF are available in the company’s newsroom at http://ibn.fm/RNWF.
